Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Agreed. That is why I posted that link for all our

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155262
(Total Views: 868)
Posted On: 08/02/2020 9:17:46 AM
Posted By: Babaji
Re: Boatbuilder #46656
Agreed. That is why I posted that link for all our enthusiastic posters to hopefully read - an unbiased explanation of the process of getting a new med qualified.

Having said that, sometimes I wish they would tone down their projecting “precise” schedules which are dependent on others and not in their control. Gets us excited only to learn of the pitfalls of these forecasts.

Our communities expectations are also often misinformed and they take on a life of their own. NP was very clear on the purpose of his last CC to present “Updates” on the current trials and next steps. Which he did and, if one was listening carefully to all the presenters (note he gave all the doctors a chance to present) there was seriously good news disseminated but carefully done!

I had to go look up the NEWS 2 protocol. Never heard of it but he was passionate about trying to tell us that this protocol will pull us over the finish line in the mm (CD10) trials. The NEWS 2 protocol is designed to measure specific metrics in a patients disease progress (see link below). The NEWS 2 protocol is used to provide standardized information to predict the potential of a patient progressing to severe status (in this trial). NP said that the data showed that the drugged arm of the mm trial outperformed the placebo arm in EVERY measurement milestone they had, day 3, day 7 and day 14! Though he could not present specific tables of data, he said THIS IS GREAT NEWS! He repeated this to a questioner as well. I choose to believe him and comfortable that we will outshine every other medicine tested similarly.

https://www.rcplondon.ac.uk/news/news2-and-de...n-covid-19

Next CD10 update will be “Too Line Results” and I hope our community understand what this means.


(8)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us